2.9 C
Canberra
Friday, April 26, 2024

Third doses for immunocompromised Canberrans now available at AIS Arena

Eligible immunocompromised people can now receive their third COVID-19 vaccination dose at the AIS Arena Mass Vaccination Clinic and other ACT Government vaccination clinics.

Rachel Stephen-Smith, ACT Minister for Health, said rolling out additional doses at ACT Government clinics would make it easier for at-risk Canberrans to get protected from COVID faster.

“We have worked hard to increase vaccination access for vulnerable people in our community,” Ms Stephen-Smith said.

Only a specific cohort of vulnerable Australians for whom two doses are not as effective can receive the additional primary dose, Ms Stephen-Smith said. This is not classified as a booster.

The Australian Technical Advisory Group on Immunisation recommends people with specific immunocompromising conditions and therapies should receive a third dose (preferably an mRNA vaccine such as Pfizer and Moderna) two to six months after their second dose, regardless of which vaccine was administered for the first two doses.

The patient must bring a letter from their treating physician when they attend their appointment.

Ms Stephen-Smith encouraged immunocompromised people to talk to their doctor about a third dose, and then call the booking line (02 5124 7700) to make an appointment.

Bookings are also available at the Access and Sensory Clinic for people who might need additional support, including those with a disability or mental health conditions.

Third vaccine doses are also available through general practitioners and pharmacists.

More Stories

Debate over Albanese’s public sector investment in clean energy

Mr Albanese’s government has announced a new plan to have the public sector as ‘a participant, a partner, an investor and enabler’ in selecting areas for support, with the focus on ‘clean energy’ and new industries.
 
 

 

Latest

canberra daily

SUBSCRIBE TO THE CANBERRA DAILY NEWSLETTER

Join our mailing lists to receieve the latest news straight into your inbox.

You have Successfully Subscribed!